Stay updated with breaking news from Peterj Facchini. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Presentations highlight research involving Enveric’s EVM301 Series of non-hallucinogenic neuroplastogens and the company’s lead product candidate, EB-373 ...
CAMBRIDGE - Enveric Biosciences, Inc. , a biotechnology company dedicated to the development of novel small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders,... | June 8, 2023
Enveric Biosciences, Inc. , a biotechnology company dedicated to the development of novel small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders, today... | June 7, 2023